Destabilization of the MiniChromosome Maintenance (MCM) complex modulates the cellular response to DNA double strand breaks

Cell Cycle. 2018;17(23):2593-2609. doi: 10.1080/15384101.2018.1553336. Epub 2018 Dec 10.

Abstract

DNA replication during S phase involves thousands of replication forks that must be coordinated to ensure that every DNA section is replicated only once. The minichromosome maintenance proteins, MCM2 to MCM7, form a heteromeric DNA helicase required for both the initiation and elongation of DNA replication. Although only two DNA helicase activities are necessary to establish a bidirectional replication fork from each replication origin, a large excess of MCM complexes is amassed and distributed along the chromatin. The function of the additional MCM complexes is not well understood, as most are displaced from the DNA during the S-phase, apparently without playing an active role in DNA replication. DNA damage response (DDR) kinases activated by stalled forks prevent the replication machinery from being activated, indicating a tight relationship between DDR and DNA replication. To investigate the role of MCM proteins in the cellular response to DNA damage, we used shRNA targeting MCM2 or MCM3 to determine the impact of a reduction in MCM complex. The alteration of MCM proteins induced a change in the activation of key factors of the DDR in response to Etoposide treatment. Etoposide-induced DNA damage affected the phosphorylation of γ-H2AX, CHK1 and CHK2 without affecting cell viability. Using assays measuring homologous recombination (HR) and non-homologous end-joining (NHEJ), we identified a decrease in both HR and NHEJ associated with a decrease in MCM complex.

Keywords: DNA damage; DNA repair; Etoposide; Homologous Recombination; MCM protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Chromatography, High Pressure Liquid
  • DNA Breaks, Double-Stranded* / drug effects
  • DNA End-Joining Repair
  • Etoposide / pharmacology
  • G1 Phase Cell Cycle Checkpoints / drug effects
  • Histones / metabolism
  • Homologous Recombination
  • Humans
  • Mass Spectrometry
  • Minichromosome Maintenance Complex Component 2 / antagonists & inhibitors
  • Minichromosome Maintenance Complex Component 2 / genetics
  • Minichromosome Maintenance Complex Component 2 / metabolism
  • Minichromosome Maintenance Complex Component 3 / antagonists & inhibitors
  • Minichromosome Maintenance Complex Component 3 / genetics
  • Minichromosome Maintenance Complex Component 3 / metabolism
  • Minichromosome Maintenance Proteins / antagonists & inhibitors
  • Minichromosome Maintenance Proteins / genetics
  • Minichromosome Maintenance Proteins / metabolism*
  • Phosphopeptides / analysis
  • Phosphorylation / drug effects
  • RNA Interference
  • RNA, Small Interfering / metabolism

Substances

  • H2AX protein, human
  • Histones
  • MCM3 protein, human
  • Phosphopeptides
  • RNA, Small Interfering
  • Etoposide
  • MCM2 protein, human
  • Minichromosome Maintenance Complex Component 2
  • Minichromosome Maintenance Complex Component 3
  • Minichromosome Maintenance Proteins

Grants and funding